Oncology Pharma Inc. (ONPH)
Sector: Shell Companies
Industry: Shell Companies
Oncology Pharma Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 0.0360 | 0.0405 | 0.0360 | 0.0405 | 3,037 |
| Nov 13, 2026 | 0.0400 | 0.0445 | 0.0360 | 0.0360 | 125,258 |
| Nov 12, 2026 | 0.0440 | 0.0440 | 0.0400 | 0.0440 | 5,352 |
| Nov 11, 2026 | 0.0400 | 0.0400 | 0.0400 | 0.0400 | 6,808 |
| Nov 10, 2026 | 0.0400 | 0.0500 | 0.0400 | 0.0400 | 27,631 |
| Nov 9, 2026 | 0.0520 | 0.0520 | 0.0400 | 0.0400 | 8,490 |
| Nov 6, 2026 | 0.0400 | 0.0500 | 0.0400 | 0.0400 | 6,220 |
| Nov 5, 2026 | 0.0400 | 0.0500 | 0.0400 | 0.0450 | 16,326 |
| Nov 4, 2026 | 0.0400 | 0.0500 | 0.0400 | 0.0400 | 3,901 |
| Nov 3, 2026 | 0.0400 | 0.0520 | 0.0400 | 0.0400 | 49,281 |
| Nov 2, 2026 | 0.0459 | 0.0479 | 0.0400 | 0.0479 | 8,159 |
| Oct 30, 2026 | 0.0400 | 0.0479 | 0.0300 | 0.0400 | 13,520 |
| Oct 29, 2026 | 0.0305 | 0.0360 | 0.0305 | 0.0360 | 2,023 |
| Oct 28, 2026 | 0.0300 | 0.0350 | 0.0300 | 0.0301 | 7,433 |
| Oct 27, 2026 | 0.0300 | 0.0460 | 0.0300 | 0.0460 | 8,590 |
| Oct 26, 2026 | 0.0351 | 0.0480 | 0.0350 | 0.0480 | 8,815 |
| Oct 23, 2026 | 0.0479 | 0.0480 | 0.0360 | 0.0480 | 17,268 |
| Oct 22, 2026 | 0.0406 | 0.0480 | 0.0331 | 0.0350 | 2,653 |
| Oct 21, 2026 | 0.0350 | 0.0519 | 0.0331 | 0.0350 | 3,283 |
| Oct 20, 2026 | 0.0408 | 0.0408 | 0.0308 | 0.0308 | 1,445 |
Oncology Pharma Inc. is a pharmaceutical firm specializing in oncology, dedicated to the development, manufacturing, and commercialization of therapeutic agents.
The company has a collaborative and licensing agreement with Kalos Therapeutics Inc. to explore treatment possibilities for the COVID-19 virus. Originally incorporated in 1993, the company was known as SourcingLink.net Inc. until it rebranded as Oncology Pharma Inc. in June 2019.
Its operations are based in San Francisco, California.
based on 82.16M shares outstanding
30d Avg
15.76K
60d Avg
16.92K
90d Avg
13.80K
Oncology Pharma Inc. (OTC: ONPH) traded at $0.0405 on Nov 16, 2026, up 12.50% from the previous close of $0.0360. 52-week range: $0.0005 to $0.3640. The company is in the Healthcare sector (Biotechnology).